Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer

Hypoxia-Inducible MiR-210 Is an Independent Prognostic Factor and Contributes to Metastasis in Colorectal Cancer

(2014) Ailin Qu et al.   PLoS One

Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer

(2013) T Kawaguchi et al.   BRITISH JOURNAL OF CANCER

Circulating miRNAs as new blood-based biomarkers for solid cancers

(2013) Martina Redova et al.   Future Oncology

Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma

(2012) An Zhao et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

microRNA expression profile in a large series of bladder tumors: Identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer

(2012) Géraldine Pignot et al.   INTERNATIONAL JOURNAL OF CANCER

Expression of miRNAs Involved in Angiogenesis, Tumor Cell Proliferation, Tumor Suppressor Inhibition, Epithelial-Mesenchymal Transition and Activation of Metastasis in Bladder Cancer

(2012) Apostolos Zaravinos et al.   JOURNAL OF UROLOGY

Synthetic miRNA-Mowers Targeting miR-183-96-182 Cluster or miR-210 Inhibit Growth and Migration and Induce Apoptosis in Bladder Cancer Cells

(2012) Yuchen Liu et al.   PLoS One

MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma

(2012) Martina Redova et al.   TUMOR BIOLOGY

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

(2011) Eun-Jung Jung et al.   CANCER

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Characterization of extracellular circulating microRNA

(2011) Andrey Turchinovich et al.   NUCLEIC ACIDS RESEARCH

Comparative mRNA and microRNA Expression Profiling of Three Genitourinary Cancers Reveals Common Hallmarks and Cancer-Specific Molecular Events

(2011) Xianxin Li et al.   PLoS One

miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo

(2010) Gui Hu et al.   CANCER BIOLOGY & THERAPY

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis

(2010) Nobuyoshi Kosaka et al.   CANCER SCIENCE

miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

(2010) M-P Puisségur et al.   CELL DEATH AND DIFFERENTIATION

Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer

(2010) S. Asaga et al.   CLINICAL CHEMISTRY

Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers

(2010) Ke Zen et al.   MEDICINAL RESEARCH REVIEWS

Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells

(2010) Lucy Pigati et al.   PLoS One

MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance

(2009) T. Moriyama et al.   MOLECULAR CANCER THERAPEUTICS

Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs

(2009) Tian Sheng Chen et al.   NUCLEIC ACIDS RESEARCH

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

(2008) Xi Chen et al.   CELL RESEARCH

EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

(2008) Marko Babjuk et al.   EUROPEAN UROLOGY

Circulating mutant DNA to assess tumor dynamics

(2008) Frank Diehl et al.   NATURE MEDICINE

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Bladder Cancer—Contemporary Dilemmas in Its Management

(2007) Peter Whelan   EUROPEAN UROLOGY